• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植中纤维性和闭塞性胆管炎:复发性原发性硬化性胆管炎的证据?

Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?

作者信息

Harrison R F, Davies M H, Neuberger J M, Hubscher S G

机构信息

Department of Pathology, Medical School, University of Birmingham, United Kingdom.

出版信息

Hepatology. 1994 Aug;20(2):356-61.

PMID:8045496
Abstract

Fibroobliterative lesions and fibrous cholangitis are characteristic histological lesions of primary sclerosing cholangitis. To determine whether such lesions can be found in the liver allograft, and whether they represent recurrent disease, we reviewed all consecutive histological material taken at greater than 6 mo after transplantation in a 3-yr period from a series of 207 liver transplantations (22 with primary sclerosing cholangitis, 185 controls without primary sclerosing cholangitis). Because patients with primary sclerosing cholangitis have a biliary system reconstructed by means of a Roux loop, we compared the findings with those from a further control group of patients who had received a Roux loop for reasons other than primary sclerosing cholangitis. Of 22 patients receiving liver transplants for primary sclerosing cholangitis, 7 (32%) patients had biopsy specimens showing features of biliary obstruction, 6 (27%) showed fibrous cholangitis, and 3 (14%) showed classic fibroobliterative lesions. These findings compared with 3 (14%), 1 (5%) and 0 of 22 Roux controls, and 19 (10%), 4 (2%) and 0 of 185 controls without primary sclerosing cholangitis, respectively. The three patients with fibroobliterative lesions either had clinical episodes of cholangitis or had microorganisms in the large bile ducts. However, both biliary obstructive features and fibrous cholangitis were more common in primary sclerosing cholangitis, and fibroobliterative lesions were found only in patients who received transplants for primary sclerosing cholangitis, despite the presence of cholangitis and Roux loops in control patients.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

纤维闭塞性病变和纤维性胆管炎是原发性硬化性胆管炎的特征性组织学病变。为了确定这些病变是否能在肝移植受者的肝脏中发现,以及它们是否代表复发性疾病,我们回顾了在3年期间207例肝移植(22例原发性硬化性胆管炎患者,185例无原发性硬化性胆管炎的对照患者)中,移植后6个月以上获取的所有连续组织学材料。由于原发性硬化性胆管炎患者的胆道系统通过Roux袢重建,我们将结果与另一组因原发性硬化性胆管炎以外的原因接受Roux袢手术的患者进行了比较。在22例因原发性硬化性胆管炎接受肝移植的患者中,7例(32%)活检标本显示胆道梗阻特征,6例(27%)显示纤维性胆管炎,3例(14%)显示典型的纤维闭塞性病变。这些结果分别与22例Roux对照组中的3例(14%)、1例(5%)和0例,以及185例无原发性硬化性胆管炎对照组中的19例(10%)、4例(2%)和0例进行比较。3例有纤维闭塞性病变的患者要么有胆管炎临床发作,要么在大胆管中有微生物。然而,尽管对照患者存在胆管炎和Roux袢,但胆道梗阻特征和纤维性胆管炎在原发性硬化性胆管炎中更为常见,且纤维闭塞性病变仅在因原发性硬化性胆管炎接受移植的患者中发现。(摘要截短于250字)

相似文献

1
Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?肝移植中纤维性和闭塞性胆管炎:复发性原发性硬化性胆管炎的证据?
Hepatology. 1994 Aug;20(2):356-61.
2
Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.肝移植后自身免疫性疾病、原发性硬化性胆管炎、原发性胆汁性肝硬化和自身免疫性肝炎的复发。
Liver Transpl. 2009 Nov;15 Suppl 2:S25-34. doi: 10.1002/lt.21916.
3
[Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].[肝穿刺活检和内镜逆行胆管造影在慢性无黄疸型不明原因胆汁淤积患者中的重要性。对79例患者的回顾性研究]
Gastroenterol Clin Biol. 1999 Feb;23(2):178-85.
4
Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.在活体肝移植后复发性原发性硬化性胆管炎中,活动性肝炎频繁重叠与疾病的快速进展过程有关。
Hum Pathol. 2011 Sep;42(9):1329-36. doi: 10.1016/j.humpath.2010.01.029. Epub 2011 Feb 21.
5
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.不同免疫抑制方案与肝移植后原发性硬化性胆管炎的复发
Liver Transpl. 2003 Jul;9(7):727-32. doi: 10.1053/jlts.2003.50143.
6
Primary sclerosing cholangitis in children: a histologic follow-up study.儿童原发性硬化性胆管炎:一项组织学随访研究
Pediatr Dev Pathol. 2005 Sep-Oct;8(5):568-76. doi: 10.1007/s10024-005-0020-0. Epub 2005 Oct 7.
7
Recurrence of primary sclerosing cholangitis in patients after liver transplantation.肝移植患者原发性硬化性胆管炎的复发
Transplant Proc. 2006 Jan-Feb;38(1):240-3. doi: 10.1016/j.transproceed.2005.12.026.
8
Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.继发性硬化性胆管炎:与原发性硬化性胆管炎的比较。
Am J Gastroenterol. 2005 Jun;100(6):1330-3. doi: 10.1111/j.1572-0241.2005.41526.x.
9
IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis.原发性硬化性胆管炎肝移植组织中 IgG4+ 浆细胞浸润。
Am J Surg Pathol. 2010 Jan;34(1):88-94. doi: 10.1097/PAS.0b013e3181c6c09a.
10
Primary sclerosing cholangitis: the emerging role for liver transplantation.原发性硬化性胆管炎:肝移植的新作用
Am J Gastroenterol. 1990 Sep;85(9):1136-41.

引用本文的文献

1
Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects.肝移植后自身免疫性肝病的复发:临床情况
Auto Immun Highlights. 2012 Oct 30;3(3):113-8. doi: 10.1007/s13317-012-0040-5. eCollection 2012 Dec.
2
Primary sclerosing cholangitis as an intractable disease.原发性硬化性胆管炎是一种难治性疾病。
Intractable Rare Dis Res. 2012 Feb;1(1):13-7. doi: 10.5582/irdr.2012.v1.1.13.
3
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎肝移植的复发与排斥。
World J Gastroenterol. 2012 Jan 7;18(1):1-15. doi: 10.3748/wjg.v18.i1.1.
4
Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.原发性硬化性胆管炎活体供肝与尸体供肝肝移植结局的比较分析
J Gastrointest Surg. 2009 Aug;13(8):1480-6. doi: 10.1007/s11605-009-0898-3. Epub 2009 May 9.
5
Endoscopic treatment of dominant stenoses in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者主要狭窄的内镜治疗
Clin Rev Allergy Immunol. 2005 Apr;28(2):159-65. doi: 10.1385/CRIAI:28:2:159.
6
Primary Sclerosing Cholangitis.
Curr Treat Options Gastroenterol. 2001 Dec;4(6):469-477. doi: 10.1007/s11938-001-0012-8.
7
Primary sclerosing cholangitis.原发性硬化性胆管炎
Clin Rev Allergy Immunol. 2000 Apr;18(2):185-214. doi: 10.1385/CRIAI:18:2:185.
8
Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.成人肝移植转诊与评估指征:临床指南。英国胃肠病学会。
Gut. 1999 Dec;45 Suppl 6(Suppl 6):VI1-VI22.
9
Primary sclerosing cholangitis: resect, dilate, or transplant?原发性硬化性胆管炎:切除、扩张还是移植?
Ann Surg. 1998 Mar;227(3):412-23. doi: 10.1097/00000658-199803000-00014.
10
Medical problems occurring after orthotopic liver transplantation.
Dig Dis Sci. 1997 Aug;42(8):1666-74. doi: 10.1023/a:1018853213442.